News

  • Letter from 115 House of Reps to CMS

    October 07, 2013
    The Honorable Marilyn B. Tavenner Administrator Centers for Medicare and Medicaid Services U.S. Department of Health and Human Services Washington, DC  20201 Dear Administrator  Tavenner: We write to express our strong opposition to a proposal in the Centers for Medicare & Medicaid Services (CMS) proposed rule updating the Medicare physician fee schedule (PFS) rates and policies for calendar year (CY) 2014.  Under the 2014 Medicare PhysicianContinue Reading »...
  • Statement on Revised Gapfill Pricing of the Molecular Diagnostic Codes

    October 01, 2013
    Statement on Revised Gapfill Pricing of the Molecular Diagnostic Codes October 1, 2013 Washington, DC – The American Clinical Laboratory Association (ACLA) issued the following statement on the Centers for Medicare & Medicaid Services’ release of the revised gapfill pricing of the molecular diagnostic codes: “On September 30th, the Centers for Medicare & Medicaid Services released the final carrier prices for the new molecular diagnostic codes, describingContinue Reading »...
  • Fee changes take a toll on lab testing industry

    September 25, 2013
    Miami Herald By Doug Van oort Many healthcare providers agree that Washington has rightfully gotten serious about unsustainable cost growth in healthcare and, specifically, in Medicare. Yet when cost cutting is taken to its extreme, with proposals that would result in below-cost reimbursement for Medicare providers, policies become penny-wise and pound-foolish. As the head of a clinical laboratory specializing in cancer testing for moreContinue Reading »...
  • Letter to Glenn Hackbarth Regarding MedPAC PFS Comments

    September 24, 2013
    Glenn M. Hackbarth, J.D., Chairman Medicare Payment Advisory Commission 425 Eye Street, NW, Suite 701 Washington, DC 20001 Dear Chairman Hackbarth: The American Clinical Laboratory Association is taking this opportunity to share our views on the recent comments submitted to the Centers for Medicare and Medicaid Services (“CMS”) by the Medicare Payment Advisory Commission (“MedPAC” or “the Commission”) with regard to the 2014 MedicareContinue Reading »...
  • ACLA Submits Comments to CMS on Physician Fee Schedule, Clinical Laboratory Fee Schedule Calls For Adequate Reimbursement for Diagnostic Services

    September 03, 2013
    WASHINGTON D.C. – The American Clinical Laboratory Association (ACLA) submitted comments to the Centers for Medicare & Medicaid Services (CMS) urging the use of reimbursement policies that recognize the essential role of diagnostic services in the healthcare delivery system and protects access to these vital services for Medicare beneficiaries. In July CMS issued a rule proposing revisions to payment policies for the Medicare ProgramContinue Reading »...
  • Comments to CMS Regarding Lab Issues ESRD PPS

    August 30, 2013
    Laurence Wilson Director, Chronic Care Policy Group Center for Medicare Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Dear Mr. Wilson: On behalf of the members of the American Clinical Laboratory Association (“ACLA”), many of whom provide services to end stage renal disease (“ESRD”) beneficiaries on renal dialysis, I am writing to express our concerns about post-regulatory issuances by theContinue Reading »...
  • Letter to Marilyn Tavenner regarding PFS Comments

    August 29, 2013
    Administrator Marilyn Tavenner Centers for Medicare and Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue SW Washington, DC 20201 RE: Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, and Other Revisions to Part B for CY 2014, Proposed Rule (CMS-1600-P) Dear Ms. Tavenner, The American Clinical Laboratory AssociationContinue Reading »...
  • New Analysis Finds Contradictions and Flaws in CMS Rationale for Cutting Anatomic Pathology Services for Medicare Beneficiaries

    August 20, 2013
      WASHINGTON D.C. – Today the American Clinical Laboratory Association (ACLA) released a report prepared by The Moran Company, a research firm with expertise in Medicare, that found serious contradictions and flaws in a recent proposal from the Centers for Medicare & Medicaid Services (CMS) to drastically cut Medicare reimbursement for anatomic pathology services. On July 8, CMS issued a rule proposing to cutContinue Reading »...
  • Joint Statement by AIM for Integrity in Medicare Applauding the Introduction of the Promoting Integrity in Medicare Act of 2013

    August 01, 2013
    The Alliance for Integrity in Medicare (AIM)— a broad coalition of medical specialty, laboratory, radiation oncology, and medical imaging groups committed to ending the practice of inappropriate physician self-referral – applauds the strong leadership of U.S. Representative Jackie Speier (D-CA14) as demonstrated through the introduction of The Promoting Integrity in Medicare Act of 2013. AIM supports this legislation, which addresses the ongoing misapplication ofContinue Reading »...
  • AIM Letter to Rep. Speier on Promoting Integrity in Medicare Act of 2013

    August 01, 2013
      The Honorable Jackie Speier U.S. House of Representatives 211 Cannon House Office Building Washington,DC 20515 Dear Representative Speier: On behalf of the members of the Alliance for Integrity in Medicare (AIM) — a broad coalition of medical specialty, laboratory, radiation oncology, and medical imaging groups committed to ending the practice of inappropriate physician self-referral — we thank you for introducing The Promoting IntegrityContinue Reading »...